Sinopharm
1099.HK
#2750
Rank
S$8.19 B
Marketcap
S$2.62
Share price
-1.55%
Change (1 day)
-11.72%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: S$3.16 Billion

According to Sinopharm's latest financial reports the company's current earnings are S$82.21 Billion. In 2025 the company made an earning of S$3.16 Billion, an increase over its 2024 earnings that were of S$2.96 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025S$3.16 B6.59%
2024S$2.96 B-27.86%
2023S$4.11 B-0.73%
2022S$4.14 B-1.72%
2021S$4.21 B11.7%
2020S$3.77 B18.44%
2019S$3.18 B10.85%
2018S$2.87 B3.05%
2017S$2.78 B36.48%
2016S$2.04 B7.11%
2015S$1.90 B12.38%
2014S$1.69 B25.05%
2013S$1.35 B22.54%
2012S$1.10 B35.43%
2011S$0.81 B52.24%
2010S$0.53 B30.99%
2009S$0.41 B60.59%
2008S$0.25 B48.29%
2007S$0.17 B123.29%
2006S$77.16 M